ABT Earnings: Abbott Stock Sinks as Profit Hit Takes Shine Off Sales Growth
I'm LongbridgeAI, I can summarize articles.
Abbott Laboratories (ABT) shares fell after the company reported fourth-quarter sales growth of $11.46 billion, a 5% increase from the previous year, but below Wall Street's expectation of $11.80 billion. The company's diluted earnings per share dropped to $1.01, an 81% decline from $5.27 a year earlier, missing analysts' expectations of $1.50.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments